2024
Treating Migraine Patients With Cardiovascular Risks
Wang K, Sico J. Treating Migraine Patients With Cardiovascular Risks. Neurology 2024, 103: e210196. PMID: 39621947, DOI: 10.1212/wnl.0000000000210196.Peer-Reviewed Original ResearchNonaspirin nonsteroidal anti-inflammatory drugsCardiovascular safety profileSafety profileCardiovascular eventsCardiovascular riskIncreased riskIncreased risk of ischemic eventsRisk of ischemic eventsNonsteroidal anti-inflammatory drugsExclusion of patientsAdverse cardiovascular eventsMyocardial infractionRisk of acute cardiovascular eventsEffective acute treatmentTreat migraine patientsRisk of myocardial infractionCOX-2 inhibitorsAnti-inflammatory drugsAcute cardiovascular eventsMigraine patientsAcute treatmentIschemic eventsManaging cardiovascular riskRandomized trialsCOX-2Radiation Therapy for the Treatment of Osteoarthritis
Yu J, Grew D, Spraker M, Beckta J, Shah C, Brower J. Radiation Therapy for the Treatment of Osteoarthritis. Practical Radiation Oncology 2024, 15: 19-24. PMID: 39503700, DOI: 10.1016/j.prro.2024.09.003.Peer-Reviewed Original ResearchConceptsRadiation therapyAssessment of treatment responseTreatment of osteoarthritisMedically refractory diseaseNonsteroidal anti-inflammatory drugsNoninvasive treatment optionCause of painCyclooxygenase-2 inhibitorsIntra-articular corticosteroid therapyAnti-inflammatory drugsCorticosteroid therapyRefractory diseaseTreatment responseTreatment optionsClinical evidenceOlder patientsTherapyCyclooxygenase-2PatientsTraditional treatmentPhysical therapyPainTreatmentOsteoarthritisTechnical considerationsAn update on the management of axial spondyloarthritis for sports medicine professionals
Danve A, Magrey M, Deodhar A. An update on the management of axial spondyloarthritis for sports medicine professionals. BMC Sports Science, Medicine And Rehabilitation 2024, 16: 211. PMID: 39375817, PMCID: PMC11460014, DOI: 10.1186/s13102-024-00998-z.Peer-Reviewed Original ResearchNonsteroidal anti-inflammatory drugsBiologic disease-modifying antirheumatic drugsMedicine practitionersImprove health-related quality of lifeSuspected axSpAHealth-related quality of lifeImprove health-related qualitySports medicine professionalsSports medicine practitionersChronic back painManagement of axial spondyloarthritisReferral of patientsDisease-modifying antirheumatic drugsCurrent treatment possibilitiesInadequately controlled diseaseQuality of lifeTargeted synthetic (ts) DMARDsFirst-line treatmentHeterogeneous clinical featuresLong-term outcomesDisease activity measuresPhysical therapyBack painChronic inflammatory diseaseMedicine professionalsUptake of Aspirin Chemoprevention in Patients With Lynch Syndrome
Singhal S, Riggs E, Ruth K, Chavez-Salas J, Chertock Y, Daly M, Hall M. Uptake of Aspirin Chemoprevention in Patients With Lynch Syndrome. JCO Precision Oncology 2024, 8: e2400562. PMID: 39546469, PMCID: PMC11573245, DOI: 10.1200/po-24-00562.Peer-Reviewed Original ResearchConceptsLynch syndromeLifetime risk of colorectal cancerColorectal cancerRisk of colorectal cancerCancer prevention optionsFactors associated with useNonsteroidal anti-inflammatory drugsDisease-related factorsChemoprevention uptakeScreening behaviorAspirin chemopreventionRelative risk reductionResearch invitationsPatients' perceptionsLifetime riskAdvocacy websitesASA/NSAID useElectronic surveyFox Chase Cancer CenterPrevention optionsCancer CenterRisk reductionMultivariate modelChemopreventive benefitsParticipants
2023
Offspring neurodevelopmental outcomes born to parents with chronic inflammatory arthritis using antirheumatic therapies: A scoping review
Chock E, Dahal S, Grimshaw A, Suter L, Liew Z, Felson D. Offspring neurodevelopmental outcomes born to parents with chronic inflammatory arthritis using antirheumatic therapies: A scoping review. Seminars In Arthritis And Rheumatism 2023, 61: 152230. PMID: 37295300, PMCID: PMC10521166, DOI: 10.1016/j.semarthrit.2023.152230.Peer-Reviewed Original ResearchConceptsChronic inflammatory arthritisOffspring neurodevelopmental outcomesAntirheumatic therapyNeurodevelopmental outcomesInflammatory arthritisTumor necrosis factor-alpha inhibitorsNecrosis factor-alpha inhibitorsNonsteroidal anti-inflammatory drugsEarly first trimesterOffspring health outcomesAnti-inflammatory drugsMeta-Analyses (PRISMA) guidelinesPreferred Reporting ItemsWeb of ScienceAttention deficit hyperactive disorderCorticosteroid useRheumatic diseasesFirst trimesterCochrane LibraryAlpha inhibitorsStudy qualityMedication safetyFetal wellbeingIndependent reviewersMost women
2022
The Use of Amniotic Membrane for Peripheral Nerve Injury in Lower Extremity Surgical Procedures
Cacace A, Haywood J, Ashkani-Esfahani S, Vrolyk M, Gianakos A, DiGiovanni C, Guss D, Waryasz G. The Use of Amniotic Membrane for Peripheral Nerve Injury in Lower Extremity Surgical Procedures. Foot & Ankle Orthopaedics 2022, 7: 2473011421s00602. PMCID: PMC9663639, DOI: 10.1177/2473011421s00602.Peer-Reviewed Original ResearchVisual analogue scorePostoperative visual analogue scoreNerve decompression proceduresAmniotic membraneDecompression proceduresPost-operative visual analogue scorePreoperative visual analogue scoreNonsteroidal anti-inflammatory drugsLower extremity nervesShort-term complicationsNerve decompression surgeryPosterior tibial nerveTime of surgeryPeripheral nerve injurySeries of patientsPost-operative infectionAnti-inflammatory drugsPro-regenerative effectsYears of ageCommon peronealDeep peronealAffected nerveAnalogue scorePostoperative complicationsSuperficial peronealMyocarditis after COVID‐19 mRNA vaccination: A systematic review of case reports and case series
Park D, An S, Kaur A, Malhotra S, Vij A. Myocarditis after COVID‐19 mRNA vaccination: A systematic review of case reports and case series. Clinical Cardiology 2022, 45: 691-700. PMID: 35652390, PMCID: PMC9286338, DOI: 10.1002/clc.23828.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccine-associated myocarditisVaccine-associated myocarditisCOVID-19 mRNA vaccinesMRNA vaccinesSystematic review of case reportsCOVID-19 vaccineReview of case reportsAverage time to onsetElevation of troponinNonsteroidal anti-inflammatory drugsCases of myocarditisDisease severity of COVID-19Time to onsetLength of hospitalizationOccurrence of myocarditisDose of COVID vaccineAnti-inflammatory drugsPain 3Severity of COVID-19Anti-COVID-19 vaccineSystematic literature searchChest painFavorable prognosisCase seriesClinical characteristicsActivation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs
Eisenstein A, Hilliard BK, Pope SD, Zhang C, Taskar P, Waizman DA, Israni-Winger K, Tian H, Luan HH, Wang A. Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs. Immunity 2022, 55: 1082-1095.e5. PMID: 35588739, PMCID: PMC9205175, DOI: 10.1016/j.immuni.2022.04.015.Peer-Reviewed Original ResearchConceptsNonsteroidal anti-inflammatory drugsAnti-inflammatory propertiesMyeloid cellsPrescription nonsteroidal anti-inflammatory drugsGrowth/differentiation factor 15Anti-inflammatory effectsDifferentiation factor 15Myeloid-specific deletionAnti-inflammatory activityAnti-inflammatory drugsNrf2-dependent mechanismKelch-like ECHTranscription factor Nrf2NSAID usageClinical outcomesCOX inhibitionPharmacologic approachesFactor 15Murine modelTissue protectionMurine myeloid cellsNuclear factorPrimary humanFactor Nrf2Nrf2Management of noninfectious scleritis
Abdel-Aty A, Gupta A, Del Priore L, Kombo N. Management of noninfectious scleritis. Therapeutic Advances In Ophthalmology 2022, 14: 25158414211070879. PMID: 35083421, PMCID: PMC8785299, DOI: 10.1177/25158414211070879.Peer-Reviewed Original ResearchNonsteroidal anti-inflammatory drugsImmunomodulatory agentsNoninfectious scleritisOral nonsteroidal anti-inflammatory drugsTreatment of scleritisInflammatory eye diseaseInflammatory bowel diseaseSystemic lupus erythematosusUse of steroidsAnti-inflammatory drugsDiffuse anteriorInitial therapyPosterior scleritisSystemic steroidsSystemic illnessSystemic therapyAutoimmune conditionsBowel diseaseLupus erythematosusCalcineurin inhibitorsRheumatoid arthritisUnderlying conditionInfectious conditionsEye diseaseScleritis24 Skin and collagen disorders
Charchaflieh J. 24 Skin and collagen disorders. 2022, 497-532. DOI: 10.1016/b978-0-323-71860-8.00033-1.Peer-Reviewed Original ResearchNonsteroidal anti-inflammatory drugsMH crisisMalignant hyperthermiaPotential deleterious effectsSkin disordersAnesthetic interventionsMalignant hyperthermia crisisSkeletal disordersTreatment of MHDisorders of muscleAnti-inflammatory drugsEffect of comorbiditiesEffects of drugsSystemic physiological effectsOpioid analgesicsAirway patencyNeuraxial anesthesiaPerformance of neuraxial anesthesiaAutoimmune disordersAirway managementDrug interactionsDermatological disordersDecreased mortalityMuscular weakness
2021
Opioid use after endoscopic skull base surgery: A descriptive, prospective, longitudinal cohort study
Rimmer RA, Scott B, Pailet J, Farrell NF, Mace JC, Detwiller KY, Smith TL, Dogan A, Gupta S, Andersen P, Cetas J, Geltzeiler M. Opioid use after endoscopic skull base surgery: A descriptive, prospective, longitudinal cohort study. International Forum Of Allergy & Rhinology 2021, 12: 160-171. PMID: 34309220, DOI: 10.1002/alr.22871.Peer-Reviewed Original ResearchConceptsPrevious opioid useEndoscopic skull base surgeryOpioid useHeadache disordersSkull base surgeryCohort studyMean postoperative pain scoreNonsteroidal anti-inflammatory drugsGreater opioid useOutpatient opioid useTotal opioid usePostoperative pain managementPostoperative pain scoresProspective cohort studyPostoperative day 8Longitudinal cohort studyHistory of headacheAnti-inflammatory drugsExcess opioidsOpioid consumptionOpioid exposurePain scoresPreoperative questionnairePublic health crisisAdult patientsAmerican Rhinologic Society expert practice statement: Postoperative pain management and opioid use after sinonasal surgery
Lee J, Levine C, Overdevest J, Higgins T, Manes R, Myhill J, Soler Z. American Rhinologic Society expert practice statement: Postoperative pain management and opioid use after sinonasal surgery. International Forum Of Allergy & Rhinology 2021, 11: 1296-1307. PMID: 34251080, DOI: 10.1002/alr.22847.Peer-Reviewed Original ResearchConceptsPostoperative painPain managementSinonasal surgeryNonsteroidal anti-inflammatory drugsUse of gabapentinPostoperative pain managementUse of opioidsEvidence-based recommendationsAnti-inflammatory drugsNonopioid medicationsPain controlOpioid usePreoperative counselingLocal anesthesiaPractice statementsPainSurgeryDelphi approachMedicationsOpioidsGabapentinAnesthesiaNonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection
Chen JS, Alfajaro MM, Chow RD, Wei J, Filler RB, Eisenbarth SC, Wilen CB. Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection. Journal Of Virology 2021, 95: 10.1128/jvi.00014-21. PMID: 33441348, PMCID: PMC8092681, DOI: 10.1128/jvi.00014-21.Peer-Reviewed Original ResearchSARS-CoV-2 infectionNonsteroidal anti-inflammatory drugsCOVID-19 pathogenesisSARS-CoV-2Anti-inflammatory drugsProduction of prostaglandinsCyclooxygenase-2Immune responseNSAID treatmentCyclooxygenase-1Enzymes cyclooxygenase-1Inflammatory responseAbility of NSAIDsAcute respiratory syndrome coronavirus 2 infectionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionSyndrome coronavirus 2 infectionSARS-CoV-2 vaccinationViral replicationPro-inflammatory cytokine responseCoronavirus 2 infectionExpression of angiotensinRelief of painPro-inflammatory cytokinesCoronavirus disease 2019 (COVID-19) pandemicHumoral immune response
2020
Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junction
Vyas M, Celli R, Singh M, Patel N, Aslanian HR, Boffa D, Deng Y, Ciarleglio MM, Laine L, Jain D. Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junction. Human Pathology 2020, 105: 67-73. PMID: 32941964, PMCID: PMC11152084, DOI: 10.1016/j.humpath.2020.08.007.Peer-Reviewed Original ResearchConceptsNonsteroidal anti-inflammatory drugsBile refluxIntestinal metaplasiaReactive gastropathyGEJ regionMucosal injuryMucosal changesGastroesophageal junctionAntral intestinal metaplasiaDistal esophageal adenocarcinomaDetailed clinical historySex-matched patientsGastric antral biopsiesAnti-inflammatory drugsGastric bile refluxMucosal inflammationProximal stomachDistal esophagusMedication usePancreatic metaplasiaPathology databaseProximal gastricAntral biopsiesClinical historyGastric biopsiesNonsteroidal Anti-inflammatory Drugs vs Cognitive Behavioral Therapy for Arthritis Pain
Fraenkel L, Buta E, Suter L, Dubreuil M, Levy C, Najem C, Brennan M, Corn B, Kerns R, Goulet J. Nonsteroidal Anti-inflammatory Drugs vs Cognitive Behavioral Therapy for Arthritis Pain. JAMA Internal Medicine 2020, 180: 1194-1202. PMID: 32702101, PMCID: PMC7372512, DOI: 10.1001/jamainternmed.2020.2821.Peer-Reviewed Original ResearchConceptsNonsteroidal anti-inflammatory drugsWOMAC pain scorePain scoresAnti-inflammatory drugsGlobal ImpressionKnee osteoarthritisMeloxicam groupMcMaster Universities Osteoarthritis Index (WOMAC) pain scoreCurrent nonsteroidal anti-inflammatory drugsLong-term clinical benefitMean differencePain score differenceParticipant global impressionWOMAC disability scoresKnee osteoarthritis painLower extremity disabilityPrimary outcome measureSignificant differencesCognitive behavioral therapy programCognitive behavioral therapyBehavioral therapy programBaseline painOsteoarthritis painTreat basisDisability scoresHemostatic Therapies for Heavy Menstrual Bleeding
Ahuja S, Recht M, Konkle B. Hemostatic Therapies for Heavy Menstrual Bleeding. 2020, 119-127. DOI: 10.1007/978-3-030-48446-0_11.Peer-Reviewed Original ResearchHeavy menstrual bleedingMenstrual blood lossNonsteroidal anti-inflammatory drugsVon Willebrand diseaseHemostatic therapyMenstrual bleedingPlatelet disordersAnti-fibrinolyticsBleeding disorder diagnosisCoagulation factor replacementHormonal contraceptive therapyInherited platelet disordersFresh frozen plasmaDiagnosis of hemophilia AContext of painHemophilia A carriersFirst-line approach to treatmentAnti-inflammatory drugsMedical management strategiesContraceptive therapyApproach to treatmentHormone therapyPlatelet transfusionsBlood lossFactor replacementRecognizing Axial Spondyloarthritis: A Guide for Primary Care
Magrey MN, Danve AS, Ermann J, Walsh JA. Recognizing Axial Spondyloarthritis: A Guide for Primary Care. Mayo Clinic Proceedings 2020, 95: 2499-2508. PMID: 32736944, DOI: 10.1016/j.mayocp.2020.02.007.Peer-Reviewed Original ResearchConceptsInflammatory back painBack painAxial spondyloarthritisHuman leukocyte antigen-B27 positivityChronic low back painNonsteroidal anti-inflammatory drugsExtra-articular manifestationsAge 45 yearsChronic back painLow back painAnti-inflammatory drugsEnglish-language articlesButtock painMorning stiffnessPeripheral arthritisSymptom onsetB27 positivityInsidious onsetAxial SpASpA featuresPrimary careEarly recognitionActive axSpAEffective therapyFamily historyEndometriosis Pain Management: a Review
Carlyle D, Khader T, Lam D, Vadivelu N, Shiwlochan D, Yonghee C. Endometriosis Pain Management: a Review. Current Pain And Headache Reports 2020, 24: 49. PMID: 32671581, DOI: 10.1007/s11916-020-00884-6.Peer-Reviewed Original ResearchConceptsSurgical managementGnRH agonists/antagonistsNonsteroidal anti-inflammatory drugsPain management optionsAnti-inflammatory drugsAgonists/antagonistsNerve ablationPresacral neurectomyMedical managementTreatment modalitiesAromatase inhibitorsChallenging diseaseSurgical techniqueReviewThe purposeNeurectomyExperimental pharmaceuticalsManagement optionsAblationHysterectomyOophorectomyEndometriosisRegimensResectionDanazolPatientsNSAIDs in CKD: Are They Safe?
Baker M, Perazella MA. NSAIDs in CKD: Are They Safe? American Journal Of Kidney Diseases 2020, 76: 546-557. PMID: 32479922, DOI: 10.1053/j.ajkd.2020.03.023.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsNonsteroidal anti-inflammatory drugsChronic kidney diseaseGlomerular filtration rateFiltration rateRisk factorsHigh pain burdenAcute kidney injuryManagement of painAnti-inflammatory drugsCKD populationNSAID useKidney injuryPain burdenPain controlHeart failureComorbid conditionsElectrolyte derangementsKidney diseaseSafety dataDrug effectsPatientsIndividualized basisDrug metabolismProgressive lossCautious useRimegepant 75 mg Is More Effective for Migraine Than Nonsteroidal Anti-inflammatory Drugs: Post Hoc Analysis of Data From 2 Phase 3 Trials (2107)
Turner I, Buse D, Blumenfeld A, Stock E, Stock D, Conway C, Jensen C, Morris B, Coric V, Croop R. Rimegepant 75 mg Is More Effective for Migraine Than Nonsteroidal Anti-inflammatory Drugs: Post Hoc Analysis of Data From 2 Phase 3 Trials (2107). Neurology 2020, 94 DOI: 10.1212/wnl.94.15_supplement.2107.Peer-Reviewed Original ResearchNonsteroidal anti-inflammatory drugsPhase 3 trialAnti-inflammatory drugsPost Hoc AnalysisHoc Analysis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply